Tracked deals
4
4 tracked deals across 2020-2024.
Operating Company
Healthcare
IntegriChain
Philadelphia, Pennsylvania, United States
IntegriChain delivers a biopharma data-driven commercialization platform (ICyte) integrating technology, data, consulting, and managed services to unify commercial workflows and optimize patient access and net revenue performance. Backed by Nordic Capital.
- Focus Areas
- Commercial Data Warehouse, Data Aggregation & Harmonization, AI/ML-enabled Analytics
- Website
- integrichain.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
2 addon · 1 buyout · 1 divestiture
IntegriChain Acquisition Volume by Year
Last 3 years
Supporting Data
Recent Transactions
-
July 9, 2024
- Buyer
- IntegriChain
- Target
- Federal Compliance Solutions (FCS)
- Industry
- Healthcare Services
- Location
- United States
- Type
- Buyout
IntegriChain has acquired Federal Compliance Solutions (FCS), a life‑sciences advisory and managed‑services firm focused on government pricing, contracting, and gross‑to‑net. The deal expands IntegriChain’s outsourcing and advisory capabilities, bringing FCS’s team of more than 60 professionals into IntegriChain’s ~750‑person global organization to deepen contracts & pricing and gross‑to‑net offerings for pharmaceutical manufacturers.
-
June 18, 2024
- Buyer
- IntegriChain
- Target
- BridgeView Data Solutions
- Seller
- BridgeView Life Sciences LLC
- Industry
- Data & Analytics
- Location
- New Jersey, United States
- Type
- Addon
IntegriChain has acquired the commercial data warehouse and data aggregation assets (DataBridge) of BridgeView Life Sciences LLC, integrating BridgeView's AI-assisted data exploration and field intelligence into IntegriChain’s ICyte platform. The deal expands IntegriChain's commercial data capabilities for pharmaceutical manufacturers and is the company's sixth acquisition and first since partnering with private equity backer Nordic Capital.
-
January 20, 2022
- Buyer
- IntegriChain
- Target
- Blue Fin Group
- Industry
- Consulting
- Location
- Pennsylvania, United States
- Type
- Addon
IntegriChain has acquired Blue Fin Group, a life-sciences focused management consulting firm that specializes in market access, commercialization strategy, and patient services. The deal brings Blue Fin's team of consultants into IntegriChain as an independent division to combine IntegriChain's ICyte data and application platform with Blue Fin's commercialization expertise, expanding end-to-end therapy launch and market access capabilities.
-
April 13, 2020
- Buyer
- IntegriChain
- Target
- Cumberland Life Sciences Division
- Seller
- Cumberland
- Industry
- Healthcare Services
- Location
- Tennessee, United States
- Type
- Divestiture
IntegriChain has acquired the Life Sciences Division of Cumberland, adding the division's employees and assets to its data and managed services platform for market access, contracts, pricing and revenue management. The deal expands IntegriChain's customer base to more than 220 life sciences manufacturers (including 20 of the top 20) and grows the combined team to over 350 professionals; Lincoln International arranged debt financing and Clearsight Advisors advised Cumberland on the sale.
Related Acquisition Pages
Healthcare Services Buyers & Acquisitions
2 tracked deals by IntegriChain.
Consulting Buyers & Acquisitions
1 tracked deal by IntegriChain.
Data & Analytics Buyers & Acquisitions
1 tracked deal by IntegriChain.
Acquisitions in New Jersey
1 tracked deal by IntegriChain.
Acquisitions in Pennsylvania
1 tracked deal by IntegriChain.
Acquisitions in Tennessee
1 tracked deal by IntegriChain.
Selling a company? Get in front of buyers like IntegriChain
Turn tracked acquisition activity into an outreach-ready buyer list.